Will Pfizer's Merger Hurt Innovation?

Forbes - NY,USA
With a megamerger that helps earnings but may hurt science, Pfizer makes a Faustian bargain with Wall Street. Wondering what to make of Pfizer's $68 billion ...
See Full Post